Skip to Main Content

Author Details

John J Ko
Alnylam Pharmaceuticals
2016
15
9
PMIDPaper TitleJournal TitlePublished Year
34717041Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.Liver Int2022
36636593Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study.JIMD Rep2022
35907153Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.Adv Ther2022
33902669Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study.Orphanet J Rare Dis2021
31512765EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.Hepatology2020
32817711Correction: Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.PLoS One2020
32614911Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.PLoS One2020
30917079The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis.J Manag Care Spec Pharm2019
30377144The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study.J Med Internet Res2018
28737986Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year.J Manag Care Spec Pharm2017
28944734Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders.J Manag Care Spec Pharm2017
28607751Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patients.Mult Scler J Exp Transl Clin2017
28737993The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.J Manag Care Spec Pharm2017
27015049Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.J Manag Care Spec Pharm2016
27683214Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review.BMC Neurol2016
  • 1 - 15 of 15

Recommended Authors

Kathleen M Andersen
Collegeville
Career Start Year 2015
Number of shared co-authors 0
Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 0
Rishi J Desai
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 0
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 0
Ameet Sarpatwari
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2009
Number of shared co-authors 0
Stacie B Dusetzina
Vanderbilt University School of Medicine, TN Vanderbilt Ingram Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Craig W Newcomb
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Mihail Samnaliev
Axtria Inc.
Career Start Year 2005
Number of shared co-authors 0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
James M Hoffman
St. Jude Children's Research Hospital Memphis
Career Start Year 2003
Number of shared co-authors 0
Jalpa A Doshi
University of Pennsylvania Perelman School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
Aaron S Kesselheim
Brigham and Women's Hospital.
Career Start Year 2001
Number of shared co-authors 0
Daniel E Ball
Lilly Research Laboratories
Career Start Year 2000
Number of shared co-authors 0
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 0
John Hsu
Mongan Institute, Massachusetts General Hospital and Harvard Medical School
Career Start Year 1999
Number of shared co-authors 0
Matthew L Maciejewski
Duke University
Career Start Year 1997
Number of shared co-authors 0
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 1
Trudy Millard Krause
School of Public Health, The University of Texas Health Science Center at Houston
Career Start Year 1997
Number of shared co-authors 0
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 0
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 0
Peter A Glassman
Center for Healthcare Innovation, VA Greater Los Angeles Healthcare System
Career Start Year 1994
Number of shared co-authors 0
Dana P Goldman
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Gerald J Dal Pan
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
Robert S Epstein
Epstein Health LLC
Career Start Year 1988
Number of shared co-authors 0
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 0
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 0
Dennis W Raisch
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0

Collaborators

Steven Bedrick
Colorado College, Oregon Health & Science University, Oregon Health and Science University
Co-authored papers 2
Thomas G DeLoughery
Oregon Health & Science University
Co-authored papers 2
William Hersh
Oregon Health & Science University
Co-authored papers 2
Steven Chamberlin
Co-authored papers 1
Michelle Nguyen
Co-authored papers 1
Alex J Wei
Alnylam Pharmaceuticals
Co-authored papers 1
Stephen Meninger
Alnylam Pharmaceuticals
Co-authored papers 1
Jigar J Amin
Co-authored papers 1
Michelle Nguyen
Co-authored papers 1
Jigar J Amin
Alnylam Pharmaceuticals
Co-authored papers 1
Stephen Meninger
Co-authored papers 1
Steven Chamberlin
Co-authored papers 1
Alex H Wei
Co-authored papers 1
Aaron M Cohen
Oregon Health & Science University
Co-authored papers 1
Release 1.2